8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001140361-25-001461
CIK 0001479290operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:11 AM ET
Size
255.8 KB
Accession
0001140361-25-001461
Documents
- 8-Kny20040698x7_8k.htmPrimary
FORM 8-K
- EX-2.1ny20040698x7_ex2-1.htm
EXHIBIT 2.1
- EX-99.1ny20040698x7_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHrvnc-20250117.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABrvnc-20250117_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PRErvnc-20250117_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-25-001461-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLny20040698x7_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 8:11 AM ET
- Size
- 255.8 KB